Stay updated with breaking news from Fim Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ORYZON announces First Patient In in NET, a collaborative Phase II basket study with iadademstat in R/R patients with neuroendocrine carcinomas
05.05.2022 - Oryzon invests $4.2 million in R&D in the first quarter 2022MADRID, Spain and CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) - Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
40th Annual J.P. Morgan Healthcare ConferenceBiotech Showcase 202211th Annual LifeSci Partners Corporate Access Event 2022H.C. Wainwright Bioconnect ConferenceBioMed Event 2022 in Paris MADRID, Spain ...